Fusen Pharmaceutical Company Limited (HKG:1652)
Hong Kong
· Delayed Price · Currency is HKD 1.130
-0.030 (-2.59%)
Apr 29, 2026, 3:57 PM HKT
HKG:1652 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | -188.78 | -36.28 | -34.61 | 16.65 | Upgrade
|
| Depreciation & Amortization | - | 41.71 | 35.8 | 34.16 | 23.79 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0 | 1.12 | 1.67 | 12.04 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0.34 | 0.31 | 37.99 | 21.02 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 104.1 | 40.62 | 21.02 | 1.97 | Upgrade
|
| Stock-Based Compensation | - | 0.81 | 1.45 | 1.15 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | 9.08 | 17.04 | -4.71 | 0.91 | Upgrade
|
| Other Operating Activities | - | 15.98 | 6.81 | 15.4 | 1.99 | Upgrade
|
| Change in Accounts Receivable | - | 72.42 | 49.86 | -90.56 | 25.97 | Upgrade
|
| Change in Inventory | - | 24.64 | -51.07 | 11.2 | -16.43 | Upgrade
|
| Change in Accounts Payable | - | -44.08 | 3.93 | 61.5 | -6.47 | Upgrade
|
| Change in Unearned Revenue | - | 14.56 | -63.66 | 64.87 | -6 | Upgrade
|
| Change in Other Net Operating Assets | - | 82.96 | -26.12 | -8.6 | -27.66 | Upgrade
|
| Operating Cash Flow | - | 133.73 | -20.18 | 110.49 | 47.77 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 131.31% | -68.82% | Upgrade
|
| Capital Expenditures | - | -60.96 | -66.24 | -23.86 | -110.13 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.17 | 0 | 1.63 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -15.34 | -22.27 | - | - | Upgrade
|
| Investment in Securities | - | 10.7 | -3.33 | 16.02 | -175.12 | Upgrade
|
| Other Investing Activities | - | -97.83 | -69.81 | -5.29 | 0.65 | Upgrade
|
| Investing Cash Flow | - | -163.42 | -161.48 | -13.13 | -282.98 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 78.9 | 60 | Upgrade
|
| Long-Term Debt Issued | - | 776.09 | 340.98 | 206.25 | 230.33 | Upgrade
|
| Total Debt Issued | - | 776.09 | 340.98 | 285.14 | 290.33 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -83.9 | -52 | Upgrade
|
| Long-Term Debt Repaid | - | -735.66 | -223.9 | -223.76 | -193.91 | Upgrade
|
| Total Debt Repaid | - | -735.66 | -223.9 | -307.66 | -245.91 | Upgrade
|
| Net Debt Issued (Repaid) | - | 40.43 | 117.07 | -22.52 | 44.42 | Upgrade
|
| Repurchase of Common Stock | - | -6.46 | -15.99 | -10.07 | -7.39 | Upgrade
|
| Common Dividends Paid | - | - | - | -6.96 | -8.31 | Upgrade
|
| Other Financing Activities | - | -17.97 | -12.58 | -12.22 | -8.19 | Upgrade
|
| Financing Cash Flow | - | 15.99 | 88.5 | -51.77 | 20.53 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.09 | -0.11 | 1.45 | -1.29 | Upgrade
|
| Net Cash Flow | - | -13.79 | -93.26 | 47.04 | -215.98 | Upgrade
|
| Free Cash Flow | - | 72.77 | -86.42 | 86.63 | -62.37 | Upgrade
|
| Free Cash Flow Margin | - | 22.32% | -15.28% | 17.62% | -16.17% | Upgrade
|
| Free Cash Flow Per Share | - | 0.10 | -0.12 | 0.12 | -0.08 | Upgrade
|
| Cash Interest Paid | - | 17.97 | 12.58 | 12.22 | 8.19 | Upgrade
|
| Cash Income Tax Paid | - | 0.85 | 11.09 | -3.33 | 9.4 | Upgrade
|
| Levered Free Cash Flow | - | 46.15 | -158.98 | 146.28 | -182.17 | Upgrade
|
| Unlevered Free Cash Flow | - | 58.73 | -151.11 | 154.02 | -177.02 | Upgrade
|
| Change in Working Capital | - | 150.5 | -87.05 | 38.41 | -30.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.